Proven biotech professional who bridges business and science.

GARY J. OLSEM

** ****** **, #* • Cambridge, MA **140 • 206-***-**** • ******@*****.***

S UMMARY

Proven biotech professional who bridges business and science; skilled at developing organizational

structures, disciplines and processes.

B USINESS D EVELOPMENT A ND M ANAGEMENT R ESULTS

Modernized supply chain acquisition lifecycle to bring equipment to market 67% faster within first six

•

months

Grew market share of sperm distribution clinic through international expansion into Canada, Australia

•

and EU from 7% to 39% of total revenue within twelve months; developed standards for country-

specific processing schemes and regulatory compliance to position the company for future market

expansion

Established an automated equipment return system and defined key monthly performance indicators

•

Standardized procedures and product offerings across three locations to provide consistent, positive

•

customer experience

Restructured and expanded a three-person research lab into a six-person shared resource cell

•

transformation and DNA processing facility

Drove database efficiency and integrity through rigorous adoption of uniform SOP and QC procedures:

•

o Increased annual DNA extractions and cell transformations from 200 to 3,000 in twelve months

o Doubled sperm lab throughput in the first six months

o Developed and delivered SOP and training programs in all positions

Reduced deal closure cycle an average of 60 days with commensurate improvement in cash-flow

•

Designed and deployed a social networking website, linking technicians from over 300 labs to facilitate

•

idea, talent and resource sharing

B IOTECHNOLOGY R ESULTS

Successfully managed the North American DNA repository for the Type I Diabetes Genetics

•

Consortium to become the #1 producing lab in the Consortium in one year

Implemented bar coding inventory management processes which increased sample ID confidence and

•

improved throughput while decreasing processing time and hard costs by 41%

Developed new and improved existing protocols for the Research Cell Bank improving Lymphocyte

•

isolation/transformation, comparative HLA typing, CODIS typing and ABO/Sex cells using Genescan,

Buccal swab/mouthwash/blood spot/PBMC/transformed B cell DNA extraction, RNA extraction, and

double-stranded DNA analysis using PicoGreen reagents

o Increased DNA extraction rates by 57% and PBMC transformation rates by 43%

Re-engineered FHCRC global DNA extraction method and trained center staff

•

P ROFESSIONAL E XPERIENCE

BioSurplus, Inc San Diego, CA

SR MANAGER, NATIONAL BRANCH OPERATIONS: Aug 2013 – Present

Responsible for all operating activities of bicoastal superstore & warehouse facilities encompassing

•

more than 60,000 square feet with 15 direct and indirect reports

Allocate internal and third party resource allocation to receive, process and deliver a continuously

•

revolving inventory of over 5,000 items including managing offsite domestic and international auctions

and product acquisitions

Strengthening customer experience and product presentation in showrooms, online and the unboxing

•

process through enhanced inventory techniques, innovative marketing strategies, durable packaging

and positive issue resolution.

OPERATIONS MANAGER: July 2012 – April 2013; Promo to BRANCH MANAGER: May 2013 – Aug 2013

Managed HQ operations for a $9M pre-owned scientific instrument sales and service provider

•

Optimized inventory by facilitating equipment acquisitions, maintaining databases, conducting inventory

•

& safety (OSHA) audits, correcting deficiencies and reconciling supplier contracts

Led operations team charged with sales fulfillment, inventory receipt and showroom setup

•

SOP program manager and returns administrator

•

Seattle Sperm Bank, LLC: Copenhagen-based sperm bank Seattle, WA

MANAGING DIRECTOR: Jan 2010 – Mar 2012

Directed all operations of a $4M sperm processing and distribution facility

•

Oversaw tissue repository including the receipt, storage and distribution of biological specimens; quality

•

assurance of processes; certifications and audits; marketing and donor acquisition; human resources;

financial management; and inventory control policies and procedures

Served as liaison between Geneticist, Director and staff in Denmark HQ and Seattle-based Medical

•

Director, Advisory Board and Owner

Fred Hutchinson Cancer Research Center (FHCRC): Research Cell Bank Seattle, WA

MANAGER/RESEARCH TECHNICIAN SUPERVISOR: Oct 2007 – Dec 2009

Managed staffing, production and business for lab with $1M annual budget

•

Developed budgets and proposals for competitive government and corporate Request For Applications;

•

analyzed and collected data; evaluated effectiveness; researched and developed new processes

Database Administrator for Transplant Genomics, Type I Diabetes and International Reference

•

Standards databases; Migrated 30,000-record Transplant Genomics database from Excel to SQL

Successfully secured funding through the Center Core Grant to position lab as a FHCRC Shared

•

Resource

SUPERVISOR/RESEARCH TECHNICIAN: April 2005 – Sept 2007

Engineered resource allocation and team output; team lead for Research Technicians I and II

•

Managed projects: Type I Diabetes Genetic Consortium, Int. Histocompatability Working Group,

•

National Disease Research Interchange and the Human Immunogenetics Program Biorepository

M ANAGEMENT E XPERTISE

Strategic and financial planning; forecasting and budgeting; team building; client relations; formulating idea s

and gaining buy-in; training; project management; deal negotiations; human resources; booking events and

travel; regulatory compliance; procurement and vendor qualification.

P UBLICATIONS

Collection and processing of whole blood for transformation of peripheral blood mononuclear cells and

extraction of DNA: the Type I Diabetes Genetics Consortium. Rosinger S, Nutland S, Mickelson E, Varney

MD, Boehm BO, Olsem GJ, …… Steffes MW, T1DGC. Clinical Trials V7, Supplement 1: S65-S74, 2010.

Identification of recombinant human papillomavirus type 16 variants. Jiang M, Xi LF, Edelstein ZR,

Galloway DA, Olsem GJ, Lin WC, Kiviat NB. Virology V394: 8-11, 2009.

P ROFESSIONAL A SSOCIATIONS

Shoreline Community College Shoreline, WA

Biotech Advisory Committee: Chair, 2009 – 2010; Member, 2008 - 2012

E DUCATION

Minnesota State University Mankato, MN

B.S. Biology, Chemistry minor, Summa Cum Laude

Shoreline Community College Shoreline, WA

Continuing Education, Biotech Studies

Contact this candidate